which targets integrin β4, a protein linked to various aggressive cancers. The company is advancing this promising cancer ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

Janssen opted not to continue with the first two integrin targets at the end of 2021, due to "a lack of target validation in the specific disease of Janssen's interest," and has now dropped the ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...